Nepsis Inc. Johnson & Johnson Transaction History

Nepsis Inc.

$404 Million
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 17, 2023	SELL	$154.35 - $166.11 $106,810 - $114,948	-692 Reduced 0.73%	94,107 $15.6 Million
Q1 2023 Apr 14, 2023	BUY	$151.05 - $180.26 $1.31 Million - $1.56 Million	8,662 Added 10.06%	94,799 $14.7 Million
Q4 2022 Jan 25, 2023	SELL	$160.2 - $179.79 $64,880 - $72,814	-405 Reduced 0.47%	86,137 $0
Q3 2022 Oct 31, 2022	BUY	$161.33 - $179.52 $3.05 Million - $3.4 Million	18,917 Added 27.97%	86,542 $14.1 Million
Q2 2022 Aug 02, 2022	BUY	$168.19 - $186.01 $11.4 Million - $12.6 Million	67,625 New	67,625 $12 Million
Q1 2020 Apr 17, 2020	SELL	$111.14 - $153.99 $4.31 Million - $5.96 Million	-38,736 Closed	0 $0
Q4 2019 Jan 23, 2020	BUY	$127.5 - $146.44 $325,635 - $374,007	2,554 Added 7.06%	38,736 $5.62 Million
Q3 2019 Oct 25, 2019	SELL	$126.95 - $142.14 $238,666 - $267,223	-1,880 Reduced 4.94%	36,182 $4.75 Million
Q2 2019 Jul 22, 2019	SELL	$131.15 - $144.24 $456,270 - $501,810	-3,479 Reduced 8.37%	38,062 $5.3 Million
Q1 2019 Apr 26, 2019	SELL	$125.72 - $139.79 $100,073 - $111,272	-796 Reduced 1.88%	41,541 $5.81 Million
Q4 2018 Feb 13, 2019	BUY	$122.84 - $147.84 $115,592 - $139,117	941 Added 2.27%	42,337 $5.46 Million
Q3 2018 Oct 25, 2018	SELL	$121.58 - $142.88 $83,160 - $97,729	-684 Reduced 1.63%	41,396 $5.72 Million
Q2 2018 Aug 06, 2018	BUY	$119.4 - $131.76 $409,064 - $451,409	3,426 Added 8.86%	42,080 $5.11 Million
Q1 2018 Apr 27, 2018	SELL	$125.1 - $148.14 $1.29 Million - $1.53 Million	-10,330 Reduced 21.09%	38,654 $4.95 Million
Q4 2017 Jan 17, 2018	SELL	$131.22 - $143.62 $28,737 - $31,452	-219 Reduced 0.45%	48,984 $6.84 Million
Q3 2017 Oct 13, 2017	SELL	$129.47 - $135.38 $690,851 - $722,387	-5,336 Reduced 9.78%	49,203 $6.4 Million
Q2 2017 Nov 14, 2017	SELL	N/A	-893 Reduced 1.61%	54,539 $7.22 Million
Q1 2017 Nov 14, 2017	SELL	N/A	-11,391 Reduced 17.05%	55,432 $6.9 Million
Q4 2016 Nov 14, 2017	BUY	N/A	2,999 Added 4.7%	66,823 $7.7 Million
Q3 2016 Nov 14, 2017	SELL	N/A	-5,442 Reduced 7.86%	63,824 $7.54 Million
Q2 2016 Nov 14, 2017	SELL	N/A	-10,512 Reduced 13.18%	69,266 $8.4 Million
Q1 2016 Nov 14, 2017	SELL	N/A	-21,534 Reduced 21.26%	79,778 $8.63 Million
Q4 2015 Nov 14, 2017	SELL	N/A	-10,720 Reduced 9.57%	101,312 $10.4 Million
Q3 2015 Nov 14, 2017	BUY	N/A	2,542 Added 2.32%	112,032 $10.5 Million
Q2 2015 Nov 14, 2017	BUY	N/A	1,806 Added 1.68%	109,490 $10.8 Million
Q1 2015 Nov 14, 2017	BUY	N/A	107,684	107,684 $10.8 Million

Others Institutions Holding JNJ

# of Institutions

4,227

Shares Held

1.7B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $410B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nepsis Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nepsis Inc. with notifications on news.

Account